v3.26.1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended
May 28, 2026
Jun. 16, 2025
Sep. 30, 2020
Jun. 30, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Sale of stock number of shares issued in transaction             9,000 518,500  
Sale of stock consideration received on transaction             $ 180,000 $ 10,370,000  
Number of shares issued for services               60,169  
Value of shares issued for services         $ 300,000 $ 903,380   $ 1,203,380  
Common stock, shares issued       27,582,752     27,582,752   27,573,752
Common stock, shares outstanding       27,582,752     27,582,752   27,573,752
Options garanted 202,000                
Shares issued price per share $ 20.00                
Share-based payment award, award vesting rights, description The stock options granted vest as follows: 10% in 18 months from grant; 15% in 36 months from grant; 20% in 54 months from grant; 25% in 72 months from grant; and, 30% in 90 months from grant date.                
Share-based payment award, award vesting rights, expiration period 10 years                
Fair market value grant             $ 3,720,990    
Other expenses       $ 84,381          
Expected term 10 years                
Expected volatility rate 104.34%                
Risk free rate of return 4.45%                
Options terminates date May 28, 2036                
Stock option expenses             484,085 1,164,408  
Unrecognized compensation cost       $ 4,564,706     $ 4,564,706    
Unrecognized compensation cost, period of recognition             5 years 5 months 23 days    
Warrants       21,000,000     21,000,000    
Outstanding warrants intrinsic value       $ 308,490,000     $ 308,490,000    
Weighted average exercise price             $ 5.31    
Weighted average remaining contractual life             3 years 3 months    
Exercisable warrants aggregate intrinsic value       102,830,000     102,830,000    
Exercisable warrants weighted average exercise price       $ 5.31     $ 5.31    
Exercisable warrants weighted average remaining contractual life             3 months    
Stock options       2,013,024     2,013,024    
Asset Purchase Agreement [Member] | Xten Capital Group Inc [Member] | Warrant [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Common stock purchase warrants exercisable     21,000,000            
Warrant exercise price     $ 5.31            
Warrant description     (i) a Series A Common Stock Purchase Warrant exercisable for 7,000,000 shares of common stock commencing on September 30, 2023 and expiring on September 30, 2026, (ii) a Series B Common Stock Purchase Warrant exercisable for 7,000,000 shares of common stock commencing on September 30, 2026 and expiring on September 30, 2029, and (iii) a Series C Common Stock Purchase Warrant exercisable for 7,000,000 shares of common stock commencing on September 30, 2029 and expiring on September 30, 2032.            
Warrants     191,594            
Asset Purchase Agreement [Member] | Xten Capital Group Inc [Member] | Series A Common Stock Warrant [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Common stock purchase warrants exercisable     7,000,000            
Asset Purchase Agreement [Member] | Xten Capital Group Inc [Member] | Series B Common Stock Warrant [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Common stock purchase warrants exercisable     7,000,000            
Asset Purchase Agreement [Member] | Xten Capital Group Inc [Member] | Series C Common Stock Warrant [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Common stock purchase warrants exercisable     7,000,000            
2019 Equity Compensation Plan [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Options garanted   20,000              
Shares issued price per share   $ 20.00              
Fair market value grant               $ 255,303  
Expected term   5 years              
Expected volatility rate   75.10%              
Risk free rate of return   4.04%              
Options terminates date   Jun. 16, 2030